Synthetic Biologics, Inc. company info

CIK 894158
IRS Number 133808303
State of incorporation NV
Business address 9605 MEDICAL CENTER DRIVE
SUITE 270
ROCKVILLE
MD
20850
Mail address 9605 MEDICAL CENTER DRIVE
SUITE 270
ROCKVILLE
MD
20850

Short summary

Synthetic Biologics, Inc. is a Maryland company, with head office located at 9605 Medical Center Drive Rockville, Maryland 20850. In 2018 the company owned a total of 10.80 million USD worth of assets, including 10.11 million USD worth of current assets. 2015 was the year when the company amassed the most assets.

Synthetic Biologics, Inc. Income Statement

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Revenue, Net 2.610
Research and development 1.583.3412.296.5114.4932.9129.1118.78
Operating Expenses 3.705.9317.3012.3420.5040.9839.2526.25
Operating Income (Loss) -17.30-12.34-20.50-40.98-39.25-26.25
Other Nonoperating Income (Expense) 0.02-0.02-0.010.1000
Income Tax Expense (Benefit) 0000000
Net income -1.71-8.15-17.07-12.32-19.78-43.74-27.26-15.17

Synthetic Biologics, Inc. Balance Sheet

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Cash and cash equivalents 3.278.396.686.887.844.7610.0513.387.139.55
Accounts Receivable, Net, Current 0.440.250
Property, Plant and Equipment, Gross 0.490.330.080.170.641.101.301.30
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -0.240.180.030.060.150.300.570.64
Goodwill 0.180.18
Total assets 9.527.259.639.2911.8416.3315.748.4210.80
Current assets 8.916.279.469.2311.7115.8214.927.6610.11
Accounts payable 0.290.280.211.088.694.561.721.220.88
Total current liabilities 0.400.400.231.2325.5015.1712.334.323.91
Total liabilities 0.400.400.230.7725.5015.4012.784.674.24
Common Stock, Value, Issued 0.030.030.050.060.070.090.130.130.01
Retained Earnings (Accumulated Deficit) -47.59-54.95-73.67-89.65-127.02-161.31-179.14-200.80-204.55

Synthetic Biologics, Inc. Cash Flow

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Net income -1.71-8.15-17.07-12.32-19.78-43.74-27.26-15.17
Depreciation 0.350.140.060.040.02
Depreciation and amortization 0.040.020.070.160.25
Accounts receivable 0.440.48-0.0100
Accounts payable -0.200.150.01-0.250.853.42-2.420.03
Deferred revenue 00
Net Cash Provided by (Used in) Operating Activities -1.15-2.88-8.92-7.72-16.08-38.89-27.90-20.20
Payments to Acquire Property, Plant, and Equipment 0.0100.010.040.050.500.570.21
Net Cash Provided by (Used in) Investing Activities 0.07-0.08-0.01-0.04-0.05-0.50-0.57-0.21
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.050.09
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.050.09
Proceeds from Issuance of Common Stock 17.5010.8013.2220.6746250
Payments for Repurchase of Common Stock 1
Net Cash Provided by (Used in) Financing Activities 1.016.9812.2012.4319.0342.6826.7118.48